Intellectual Medicine’s Post

August 1 is #WorldLungCancerDay. The American Cancer Society predicts that there will be more than 100,000 deaths from #LungCancer this year. When lung cancer is found at an earlier stage before it spreads, it’s more likely to be treated successfully. That’s why it’s so important that more individuals get screened – even if they may not be experiencing symptoms. At On Target, we’re committed to helping patients and doctors fight this disease. Our targeted intraoperative molecular imaging agent helps surgeons visualize early-stage lung cancer, remove more cancer during surgery, and contributes to a world with better #LungHealth. #WLCD24   To learn more about our intraoperative molecular imaging agent and risk related information, please visit https://bit.ly/3yr0tVN

𝐃𝐚𝐲 𝟓 𝐨𝐟 𝐁𝐫𝐞𝐚𝐬𝐭 𝐜𝐚𝐧𝐜𝐞𝐫! Today, we’re diving into the crucial treatment options available for breast cancer. From surgery to radiation therapy and the innovative use of the perfusor during chemotherapy, each treatment is a tailored approach that empowers patients in their fight against cancer. Understanding these options is vital for making informed decisions alongside your healthcare team. This knowledge can be a powerful ally on the journey to recovery. We hope this series has equipped you with valuable insights and encourages ongoing conversations about breast cancer awareness. #zuvius #cancer #cancerawareness #fightcancer #beatcancer Nimishh Thakkar; Shailesh Shetty; Alka Chavan; Swapnil Kamble

High-dose vitamin D significantly reduced bone loss in patients with prostate cancer - Luke Peppone https://lnkd.in/gUTeamUV #oncodaily #oncology #cancer #research #prostatecancer #ClinicalTrials

Metastatic cancer is responsible for the majority of cancer-related deaths since surgery and subsequent radio- or chemotherapy often fail to remove all cancer cells. In addition, metastases frequently develop immunosuppressive resistance mechanisms protecting them from immunotherapy that work well in primary tumors. Researchers at Technische Universität München developed cells to be used in NK-or T-cell based therapies that overcome the immunosuppressive tumor microenvironment and thus retain their full cytotoxic activity. To read more click here: https://lnkd.in/ddSNnbT9

Multidisciplinary Treatment Approach for Rectal Cancer – Discussion with Drs. Deb Schrag & Krishan Jethwa The discussion revolves around the findings of the Prospect study, which explored the possibility of avoiding radiation in select rectal cancer patients to minimize long-term side effects. The study showed that outcomes were comparable between traditional treatment methods and the selective approach, with a quality-of-life advantage for the latter. The hosts and guests also touch upon the evolving paradigm of radiation therapy, the importance of MSI high status testing, and the considerations for omitting surgery in certain cases. They emphasize the need for a multidisciplinary approach and tailoring treatment based on individual patient characteristics. Overall, the episode highlights the significance of personalized treatment strategies in managing locally advanced rectal cancer and the importance of staying abreast of the latest research and advancements in the field. See Live Session: https://lnkd.in/dzEBEsyc Learn more: https://lnkd.in/d-5AhY83 #cancertreatment #oncologypodcast #oncologistsnearme

📢 Understanding Stage 3 – Locally Advanced Breast Cancer Dr. Pratik Patil sheds light on Stage 3 breast cancer, a critical phase where cancer has spread to nearby tissues and lymph nodes but not distant organs. This stage requires a comprehensive treatment approach, often combining surgery, chemotherapy, radiation, and targeted therapy. Early detection and prompt treatment can significantly improve outcomes. Let's raise awareness and support those battling this challenging journey. 💪 Don't hesitate, to reach out to our esteemed oncologists today for the care you deserve. For more Update : https://lnkd.in/dXv4SY3x 👉For More Details ☎Call: 09637439163 🌎Web: https://lnkd.in/eY8yZ8Gi #BreastCancerAwareness #HealthyLiving #CancerPrevention #DrPratikPatil #HealthAwareness #CancerCare #CancerResearch #HealthcareInnovation #FightCancer #DrPratikPatil #MedicalAdvancements #Oncology #CompassionateCare #Expertise #Healthcare 🩺 #CancerTreatment #QualityOfLife #CancerFighter #HealthyEating #RecoveryJourney #drpratikpatil #pune #baner #balewadi #satara

Mr Sheng Qiu is a Consultant Colorectal and General Surgeon with a special interest in advanced and complex colorectal cancer. Mr Qiu has experience in pelvic exenteration surgery for locally advanced and recurrent rectal cancers. He also works with liver surgeons performing simultaneous bowel and liver resections, treating patients with metastatic colorectal cancer. Mr Qiu's research interests include novel biomarkers in cancer, personalisation of cancer treatment, and the consequences of colorectal cancer treatment. Read his full profile: https://bit.ly/3U3Lo58 #LikeNoOther #BowelCancerAwarenessMonth

Rutgers Cancer Institute Oncologist Spotlight ⭐ Haejin In, MD MPH MBA's clinical expertise and research interests are dedicated to improving the quality of care in the outcomes of gastrointestinal (GI) cancer patients, including stomach, esophageal, pancreas and peritoneal surface malignancies. Clinically, her focus has been in providing state-of-the-art, minimally invasive surgeries, particularity for #StomachCancer, while adhering to the most rigorous of oncologic surgery principles to provide those with cancer the greatest chance of cure. Learn more about Dr. In https://lnkd.in/e6mFKiuZ RWJBarnabas Health #StomachCancerAwareness #StomachCancerAwarenessMonth #Cancer

𝐃𝐚𝐲 𝟓 𝐨𝐟 𝐏𝐫𝐨𝐬𝐭𝐚𝐭𝐞 𝐜𝐚𝐧𝐜𝐞𝐫! 🎗️ As we wrap up our Prostate Cancer Series, it’s time to explore treatment options. 🌟 From hormone therapy to surgery and radiation, knowing these can help you and your doctor choose the best path forward.🧑⚕️🩺 Check out our reel for a snapshot of these treatments and their roles in managing prostate cancer.💡🌟 #zuvius #cancer #CancerAwareness #fightcancer #beatcancer Nimishh Thakkar; Shailesh Shetty; Alka Chavan; Swapnil Kamble

In the latest episode of my podcast, “The Immuno-Oncology Curve,” I'm joined by my Agenus colleagues Dr. Joseph Grossman and Dr. Benny Johnson. We talk about why we left the practice of medicine for Agenus. And, we reflect on this year’s #ASCO GI Cancers Symposium, covering the rise of early-onset cancers, the promising use of circulating tumor DNA (ctDNA) as a biomarker, the ongoing challenge of diversity in cancer clinical trials, and the overall potential of I-O to reduce dependence on chemotherapy and surgery. Listen and subscribe at: https://bit.ly/4bNIAzJ